Reviewer Disclosures.

Reviewer	Employment	Research grant	Other research support	Speakers’ bureau/honoraria	Expert witness	Ownership interest	Consultant/advisory board	Other
Andrew P. Landstrom	Duke University School of Medicine	None	None	None	None	None	None	None
Naveen L. Pereira	Mayo Clinic Rochester	None	None	None	None	None	None	None
Samuli Ripatti	Institute for Molecular Medicine, Finland, FIMM (Finland)	None	None	None	None	None	None	None
Jerome I. Rotter	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	NIH*; Sanford Health System*	None	None	None	None	None	None

This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

^*Significant.